Cubist Systematic Strategies, LLC Castle Biosciences Inc Transaction History

Cubist Systematic Strategies, LLC

  • $14.3 Billion
  • Q2 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 92,475 shares of CSTL stock, worth $2.58 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
92,475
Previous 92,475 -0.0%
Holding current value
$2.58 Million
Previous $2.01 Million -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$18.84 - $24.94 $202,172 - $267,631
10,731 Added 13.13%
92,475 $2.01 Million
Q1 2024

May 15, 2024
BUY
$18.06 - $25.3 $208,195 - $291,658
11,528 Added 16.42%
81,744 $1.81 Million
Q4 2023

Feb 14, 2024
SELL
$12.19 - $22.43 $808,452 - $1.49 Million
-66,321 Reduced 48.57%
70,216 $1.52 Million
Q3 2023

Nov 14, 2023
BUY
$13.28 - $20.3 $1.18 Million - $1.8 Million
88,647 Added 185.11%
136,537 $2.31 Million
Q2 2023

Aug 14, 2023
BUY
$11.66 - $26.0 $148,933 - $332,098
12,773 Added 36.37%
47,890 $657,000
Q1 2023

May 15, 2023
BUY
$19.47 - $28.49 $32,768 - $47,948
1,683 Added 5.03%
35,117 $797,000
Q4 2022

Feb 14, 2023
SELL
$18.08 - $30.0 $364,474 - $604,770
-20,159 Reduced 37.61%
33,434 $787,000
Q3 2022

Nov 14, 2022
SELL
$22.51 - $34.32 $1.88 Million - $2.87 Million
-83,637 Reduced 60.95%
53,593 $1.4 Million
Q2 2022

Aug 15, 2022
BUY
$16.0 - $45.99 $1.64 Million - $4.71 Million
102,397 Added 293.97%
137,230 $3.01 Million
Q1 2022

May 16, 2022
SELL
$33.17 - $46.98 $156,164 - $221,181
-4,708 Reduced 11.91%
34,833 $1.56 Million
Q4 2021

Feb 14, 2022
BUY
$39.06 - $67.58 $1.29 Million - $2.22 Million
32,913 Added 496.58%
39,541 $1.7 Million
Q3 2021

Nov 15, 2021
BUY
$60.13 - $77.6 $54,357 - $70,150
904 Added 15.79%
6,628 $441,000
Q2 2021

Aug 16, 2021
SELL
$50.07 - $76.78 $169,086 - $259,286
-3,377 Reduced 37.11%
5,724 $420,000
Q1 2021

May 17, 2021
BUY
$58.92 - $97.33 $263,843 - $435,843
4,478 Added 96.86%
9,101 $623,000
Q4 2020

Feb 16, 2021
SELL
$43.6 - $73.05 $596,927 - $1 Million
-13,691 Reduced 74.76%
4,623 $310,000
Q3 2020

Nov 16, 2020
BUY
$38.47 - $52.03 $681,803 - $922,127
17,723 Added 2998.82%
18,314 $942,000
Q2 2020

Aug 14, 2020
SELL
$27.28 - $43.01 $41,165 - $64,902
-1,509 Reduced 71.86%
591 $22,000
Q1 2020

May 15, 2020
BUY
$23.08 - $35.53 $48,468 - $74,613
2,100 New
2,100 $63,000

Others Institutions Holding CSTL

# of Institutions
171
Shares Held
25.5M
Call Options Held
511K
Put Options Held
130K
View Full List

About CASTLE BIOSCIENCES INC

CSTL Quotes by TradingView
  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $733M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email